17/05/2024  17:35:15 Diferencia +3.75 Volumen Bid17:35:15 Ask17:35:15 Capitalización de mecado Dividendo A. P/E Ratio
1,025.00GBX +0.37% 384,392
Volumen de negocios(GBP): 3.94 millones
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 8.96 mil millonesGBP - -

Descripción de negocio

Smith & Nephew plc is a global medical technology business. The company has two reportable business segments: Advanced Surgical Devices (Orthopaedic Reconstruction, Trauma & Extremities, Sports Medicine and Arthroscopy Enabling Technologies) and Advanced Wound Management. Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. The company has distribution channels, purchasing agents and buying entities in over 100 countries worldwide. Smith & Nephew plc is headquartered in London, UK.
 

Consejo de gestión & Consejo de supervisión

CEO
Deepak Nath
Consejo de gestión
John Rogers, Brad Cannon, Paul Connolly, Phil Cowdy, Myra Eskes, Mizanu Kebede, Elga Lohler, Vasant Padmanabhan, Alison Parkes, Helen Barraclough, Scott Schaffner
Consejo de supervisión
Roberto Quarta, Rupert Soames, Deepak Nath, Marc Owen, Jo Hallas, John Ma, Angie Risley, Bob White, Katarzyna Mazur-Hofsaess, Rick Medlock, John Rogers
 

Datos de la empresa

Nombre: Smith & Nephew plc
Dirección: Building 5, Croxley Park Hatters Lane Watford,Hertfordshire WD18 8YE UK
Teléfono: +44-1923-477-100
Fax: -
E-mail: -
Internet: www.smith-nephew.com/
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: -
Fecha de OPI: -

Relación con inversores

Nombre: Andrew Swift
IR teléfono: +44-117-378-5450
IR-fax: -
IR e-mail: Investorrelations.gl...hew.com Investorrelations.global@smith-nephew.com

Calendario de la empresa

CW 21 | 22/05/2024 Dividend Payment
CW 31 | 01/08/2024 Interim Report 2nd Quarter/6 Months
 

Accionistas mayoritarios

Otros
 
94.80%
BlackRock, Inc.
 
5.20%